Multi-Site STARgraft (10401) Trial (NCT07557862)
Multi-Site Randomized Controlled Trial of STARgraft (10401) Vascular Graft for Hemodialysis Access
🩺 Plain-English Summary (8th-Grade Level)
This is a multi-site, single-blind with parallel group, randomized controlled trial of Healionics STARgraft (10401) vascular graft for hemodialysis access compared with a market-leading commercially available ePTFE vascular graft (Gore Propaten Vascular Graft).
Who can join: Review the eligibility criteria below.
Location: Afya Hospital Dia, Brasília. — Brasília
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (7 Sites)
- Afya Hospital Dia, Brasília. — Brasília,
- Hospital Baía Sul — Florianópolis,
- Royal Portuguese Beneficent Hospital in Pernambuco — Recife,
- Pedro Ernesto University Hospital — Rio de Janeiro,
- Hospital Ana Nery — Salvador,
- Clinica Farallones — Cali,
- Medellín Clinic - El Poblado — Medellín,
📞 Contact the Study Coordinator
Phone: (206) 432-9060
Email: ashleigh@healionics.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in End Stage Renal Disease (ESRD)
- Autologous Adipose Derived Mesenchymal Stem Cells (AMSC) in Reducing Hemodialysis Arteriovenous Fistula Failure — Rochester, Minnesota
- Outcome of BCF Access in Hemodialysis Patients — Chicago, Illinois
- To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis — Scottsdale, Arizona
- Expanded Hemodialysis Versus High-Volume Online Hemodiafiltration for Uremic Toxin Removal — Mexico City, Mexico City
- A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease — Phoenix, Arizona
Explore by condition: All End Stage Renal Disease (ESRD) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.